Below are the most recent publications written about "Angiotensin-Converting Enzyme Inhibitors" by people in Profiles.
-
Shoji S, Kaltenbach L, Granger BB, Fonarow GC, Al-Khalidi HR, Albert NM, Butler J, Allen LA, Lanfear DE, Thibodeau JT, Chapman BM, Oliver-McNeil SM, Felker GM, Pina IL, Granger CB, Hernandez AF, DeVore AD. Guideline-Directed Medical Therapy After Hospitalization for Acute Heart Failure: Insights From the CONNECT-HF. J Am Heart Assoc. 2024 Dec 17; 13(24):e036998.
-
Tito S, Manzano JMM, Ogunmola I, Prendergast A, Patel A, Casipit B, Cantu-Martinez O, Jarrett SA, Chiang B, Sarvottam K, Azmaiparashvili Z, Lo KB, Rangaswami J. Cardiovascular Outcomes After Angiotensin Converting Enzyme Inhibitor Induced Angioedema: A Retrospective Cohort Analysis. Am J Cardiol. 2023 Oct 15; 205:393-395.
-
Weight N, Moledina S, Zoccai GB, Zaman S, Smith T, Siller-Matula J, Dafaalla M, Rashid M, Nolan J, Mamas MA. Impact of pre-existing vascular disease on clinical outcomes. Eur Heart J Qual Care Clin Outcomes. 2022 Dec 13; 9(1):64-75.
-
Moledina SM, Mannan F, Weight N, Alisiddiq Z, Elbadawi A, Elgendy IY, Fischman DL, Mamas MA. Impact of QRS Duration on Non-ST-Segment Elevation Myocardial Infarction (from a National Registry). Am J Cardiol. 2022 11 15; 183:1-7.
-
Keith SW, Maio V, Arafat HA, Alcusky M, Karagiannis T, Rabinowitz C, Lavu H, Louis DZ. Angiotensin blockade therapy and survival in pancreatic cancer: a population study. BMC Cancer. 2022 Feb 07; 22(1):150.
-
Sasongko TH, Nagalla S. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. Cochrane Database Syst Rev. 2021 12 21; 12:CD009191.
-
Freidel MR, Armen RS. Modeling the Structure-Activity Relationship of Arbidol Derivatives and Other SARS-CoV-2 Fusion Inhibitors Targeting the S2 Segment of the Spike Protein. J Chem Inf Model. 2021 12 27; 61(12):5906-5922.
-
Martinez Manzano JM, Lo KB, Jarrett SA, Chiang B, Quintero E, Aguilar F, Azmaiparashvili Z, Eiger G, Patarroyo-Aponte G. Risk factors associated with intubation and readmissions in patients with angioedema: A single-center experience al. / Ann Allergy Asthma Immunol 127 (2021) xxx-xxx"?>. Ann Allergy Asthma Immunol. 2021 12; 127(6):682-688.e1.
-
Sattar Y, Mukuntharaj P, Zghouzi M, Suleiman AM, Attique H, Ullah W, Sana MK, Zaher N, Mehmood M, Doshi RP, Panchal A, Mir T, Nadeem M, Ali OE, Mohamed M, Bagur R, Elgendy IY, Mamas MA, Alraies MC. Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population. High Blood Press Cardiovasc Prev. 2021 Jul; 28(4):405-416.
-
Martinez Manzano JM, Lo KB, Patarroyo-Aponte G, Azmaiparashvili Z. The use of intravenous tranexamic acid for patients with angiotensin-converting enzyme inhibitor-induced angioedema: A case series. Ann Allergy Asthma Immunol. 2021 06; 126(6):725-726.